This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Neuro-ophthalmology  • Glaucoma  • Alert me on articles by topic

Hypoxia-Inducible Factor 1 in the Glaucomatous Retina and Optic Nerve Head

Gülgün Tezel, MD; Martin B. Wax, MD

Arch Ophthalmol. 2004;122:1348-1356.

Objective  To examine tissue hypoxia in the retina and optic nerve head of glaucomatous eyes by the assessment of a transcription factor, hypoxia-inducible factor 1 (HIF-1), which is tightly regulated by the cellular oxygen concentration.

Methods  Using immunohistochemical analysis, the cellular localization of HIF-1 was studied in the retina and optic nerve head of 28 human donor eyes with glaucoma compared with 20 control eyes from healthy donors matched for several characteristics. The relationship between the retinal regions that exhibited immunostaining for HIF-1 and functional damage was examined using visual field data.

Results  There was an increase in the immunostaining for HIF-1 in the retina and optic nerve head of glaucomatous donor eyes compared with the control eyes. In addition, the retinal location of the increased immunostaining for HIF-1 in some of the glaucomatous eyes was closely concordant with the location of visual field defects recorded in these eyes.

Conclusions  Because the regions of HIF-1 induction represent the areas of decreased oxygen delivery and hypoxic stress, information obtained from this study provides direct evidence that tissue hypoxia is present in the retina and optic nerve head of glaucomatous eyes, and hypoxic signaling is a likely component of the pathogenic mechanisms of glaucomatous neurodegeneration.

Clinical Relevance  These findings support the presence of tissue hypoxia in the retina and optic nerve head of glaucomatous patients.

From the Department of Ophthalmology and Visual Sciences and Department of Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, Ky (Dr Tezel); Alcon Laboratories, Ft Worth, Tex (Dr Wax); and Department of Ophthalmology, University of Texas Southwestern Medical School, Dallas (Dr Wax). The authors have no relevant financial interest in this article.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Phosphorylation-Dependent Interaction with 14-3-3 in the Regulation of Bad Trafficking in Retinal Ganglion Cells
Yang et al.
IOVS 2008;49:2483-2494.
ABSTRACT | FULL TEXT  

Antiangiogenic Characteristics of Astrocytes From Optic Nerve Heads With Primary Open-angle Glaucoma
Rudzinski et al.
Arch Ophthalmol 2008;126:679-685.
ABSTRACT | FULL TEXT  

Neuroglobin in normal retina and retina from eyes with advanced glaucoma
Rajendram and Rao
Br. J. Ophthalmol. 2007;91:663-666.
ABSTRACT | FULL TEXT  

Accelerated Aging in Glaucoma: Immunohistochemical Assessment of Advanced Glycation End Products in the Human Retina and Optic Nerve Head
Tezel et al.
IOVS 2007;48:1201-1211.
ABSTRACT | FULL TEXT  

Blood flow in glaucoma
Orgul
Br. J. Ophthalmol. 2007;91:3-5.
FULL TEXT  

Neuroglobin and cytoglobin: oxygen-binding proteins in retinal neurons.
Ostojic et al.
IOVS 2006;47:1016-1023.
ABSTRACT | FULL TEXT  

Proteomic Identification of Oxidatively Modified Retinal Proteins in a Chronic Pressure-Induced Rat Model of Glaucoma
Tezel et al.
IOVS 2005;46:3177-3187.
ABSTRACT | FULL TEXT  

Caspase-Independent Component of Retinal Ganglion Cell Death, In Vitro
Tezel and Yang
IOVS 2004;45:4049-4059.
ABSTRACT | FULL TEXT